The Tentamus Group announces a change in its country leadership. Effective July 1st, 2025, Nicola Berruti, Country Manager Tentamus Italy has been appointed as Country Manager for Tentamus Italy & UK. Nicola Berruti succeeds Dr. Frederick J. Stubbins, who will be pursuing new professional opportunities. “We are grateful for Fredericks commitment and efforts over the […]
Read More
CONIDIA CONIPHY has added a new service to its portfolio to detect and monitor fungicide resistance of downy mildew disease in grapevine. After 5 years of research, development efforts and investment in new DNA/gene sequencing technologies, CONIDIA CONIPHY launched a new innovative method/tool: Fungi RESIST. Fungi RESIST can alert and measure resistance against fungicides used […]
Read More
As the risk of Legionnaires‘ disease remains a critical public health concern, Tentamus North America is reinforcing its commitment to facility safety by highlighting its expert Legionella testing services for industries across the continent. The company is providing advanced, reliable testing solutions designed to help facility owners and managers proactively identify and mitigate Legionella contamination in building water systems. […]
Read MoreTurning breakthrough science into effective therapies requires more than innovation — it demands the right expertise, infrastructure, and seamless execution. This complexity is addressed by ClinXTrials – a powerhouse alliance based in Vienna. Gouya Insights, VelaLabs – a Tentamus company -, and ABF Pharmaceutical Services offer a one-stop solution to accelerate development and de-risk clinical […]
Read More
Bahnbrechende wissenschaftliche Erkenntnisse in wirksame Therapien zu überführen, erfordert mehr als nur Innovation – es bedarf der richtigen Expertise, Infrastruktur und reibungsloser Durchführung. Diese Komplexität wird bei ClinXTrials adressiert. Gouya Insights, VelaLabs – a Tentamus company – und ABF Pharmaceutical Services, drei innovative Unternehmen aus Wien, bieten gemeinsam eine integrierte Lösung an, um Entwicklungsprozesse zu […]
Read More
Since its founding in August 1995 as Dr. Kolkmann & Partner GmbH, the company has developed into an established player in the field of pharmaceutical analytics and drug research. Over the course of three decades, the site has undergone an impressive transformation. In 2008, the company was renamed Diapharm Analytics GmbH before being integrated into […]
Read More
Der Standort Oldenburg der Tentamus Pharma & Med Deutschland GmbH feiert in diesem Jahr sein 30-jähriges Bestehen. Seit der Gründung im August 1995 als Dr. Kolkmann & Partner GmbH hat sich das Unternehmen zu einer etablierten Größe im Bereich pharmazeutischer Analytik und Arzneimittelforschung entwickelt. Im Laufe der drei Jahrzehnte durchlief der Standort eine beeindruckende Entwicklung. […]
Read More
Minerva Scientific – A Tentamus Company is a Food and Feed testing laboratory established in 2001, offering a wide range of ISO 17025 accredited tests ideal for due diligence-based surveillance testing, pertinent to UK and EU legislative requirements. Notably, our team at Minerva Scientific are the leading experts in Honey testing in the UK. In […]
Read More
We now offer a new analytical method, Headspace SPME (solid phase microextraction), which is suitable for routine aroma analysis as well as for special analytical questions! Do you remember our article from last summer, in which we introduced you to our new Headspace SPME GC-MS? Back then, it was just an announcement of things to […]
Read More
Karsten Ott war über drei Jahrzehnte eine tragende Säule unseres Unternehmens. Seit seinem Eintritt in die bilacon im Jahr 1992 prägte er maßgeblich die Entwicklung und das Wachstum des Labors. Er leitete bis 2018 mit außerordentlicher Expertise die Abteilung für Instrumentelle Analytik, bevor er die Verantwortung für den Standort Berlin übernahm. Im Jahr 2022 wurde […]
Read More